+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Alpha 1-3 Fucosyltransferases Global Market

Alpha 1-3 Fucosyltransferases Global Market

Global Alpha 1-3 Fucosyltransferases Market Research Report 2025

This report on the global alpha 1-3 fucosyltransferases market research report 2025 offers a comprehensive analysis of market size, growth drivers, emerging trends,

Pages: 210

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Alpha 1-3 Fucosyltransferases Market Overview Chem Reports estimates that the global Alpha 1-3 Fucosyltransferases market was valued at USD xxxx units in 2024 and is expected to reach USD xxxx units by 2035, growing at a CAGR of xx% during the forecast period 2025–2035.

Alpha 1-3 Fucosyltransferases are a group of glycosyltransferase enzymes that catalyze the transfer of fucose residues in glycoprotein and glycolipid biosynthesis. These enzymes play a critical role in cell adhesion, immune response, inflammation, cancer biology, and host–pathogen interactions. As a result, they are widely used in biomedical research, diagnostics development, drug discovery, and glycoengineering applications.

The market is driven by increasing investment in life sciences research, biopharmaceutical development, and glycoscience, along with expanding applications in immunology, oncology, and molecular biology. The study incorporates extensive primary interviews and secondary data analysis to evaluate market structure, technological progress, and long-term growth potential.

Impact of COVID-19 on the Alpha 1-3 Fucosyltransferases Market

The COVID-19 pandemic had a mixed impact on the Alpha 1-3 Fucosyltransferases market in 2020. Temporary disruptions in laboratory operations, research funding cycles, and supply chains negatively affected short-term demand.

However, the pandemic also accelerated biomedical and immunological research, particularly studies related to immune signaling, glycosylation mechanisms, and host–virus interactions, which supported a faster recovery. Demand from academic institutes, research laboratories, and biotech companies strengthened from late 2021 onward.

Market Segmentation Analysis

By Type

FUT3

  • Involved in Lewis antigen biosynthesis
  • Widely used in cancer and immunology research

FUT4

  • Plays a role in leukocyte adhesion and inflammatory responses
  • Strong demand from cell biology and immunological studies

FUT5

  • Applied in glycoprotein synthesis and disease pathway analysis
  • Moderate but steady research demand

FUT6

  • Associated with inflammatory diseases and infection-related pathways
  • Increasing relevance in translational research

FUT7

  • Key enzyme in selectin ligand formation
  • High usage in immune response and hematology research

Others

  • Includes less commonly studied fucosyltransferases
  • Used in exploratory and niche research applications

By Application

Human

  • Largest application segment
  • Extensively used in clinical research, oncology, immunology, and drug discovery
  • Driven by personalized medicine and biomarker development

Mouse

  • Widely used in preclinical studies and genetic research
  • Strong demand from academic and pharmaceutical R&D labs

Monkey

  • Applied in advanced translational and comparative studies
  • Limited but high-value research applications

Others

  • Includes other animal models and in-vitro systems
  • Used in experimental glycoscience research

Competitive Landscape and Key Players Analysis

The Alpha 1-3 Fucosyltransferases market is highly fragmented, with competition centered on product specificity, antibody and enzyme purity, validation data, and global distribution capability. Companies focus on expanding recombinant enzyme portfolios, improving assay compatibility, and supporting translational research.

Key players operating in the global market include:

  • R&D Systems
  • Thermo Fisher Scientific
  • Abcam
  • Abbexa
  • Abbiotec
  • Abgent
  • Abnova
  • antibodies-online
  • Assay Biotechnology
  • Aviva Systems Biology
  • Bioss
  • Cloud-Clone
  • Cohesion Biosciences
  • CUSABIO
  • DLDEVELOP
  • EIAab
  • Elabscience
  • Enogene Biotech
  • Novus Biologicals

Regional Analysis

North America

  • Dominant regional market due to strong biomedical research infrastructure
  • High funding levels for life sciences and biotechnology
  • Presence of leading reagent and antibody manufacturers

Europe

  • Significant market supported by academic research institutes and pharmaceutical R&D
  • Strong focus on glycoscience, immunology, and cancer research
  • Stable regulatory and funding environment

Asia-Pacific

  • Fastest-growing regional market
  • Rapid expansion of biotechnology research in China, Japan, South Korea, and India
  • Increasing government support for life sciences innovation

South America

  • Emerging market with growing academic research activity
  • Gradual increase in adoption of advanced research reagents

Middle East & Africa

  • Early-stage market development
  • Growth supported by expanding healthcare research infrastructure and international collaborations

Key Competitive Strategies

  • Expansion of recombinant enzyme and antibody portfolios
  • Focus on high-validation research-grade products
  • Strengthening global distribution and e-commerce channels
  • Collaboration with academic and pharmaceutical research institutions

DRTO Analysis (Drivers, Restraints, Trends & Opportunities)

Drivers

  • Expansion of biomedical research and life sciences R&D, increasing the use of enzymes and reagents such as Alpha 1-3 Fucosyltransferases.
  • Rising focus on glycoscience, immunology, oncology, and cell signaling studies, where fucosylation plays a critical role.
  • Growth of biopharmaceutical development and demand for specialized enzymes in drug discovery and biomarker identification.
  • Increasing adoption in preclinical research and translational studies using human and animal models.
  • Expansion of recombinant enzyme production and improved supplier distribution networks.

Restraints

  • High cost of research-grade enzymes and validated reagents, limiting accessibility in resource-constrained research settings.
  • Complex regulatory frameworks for biological products in certain regions.
  • Dependence on academic and industrial research funding, which may fluctuate with economic cycles.
  • Technical challenges in enzyme stability, consistency, and validation across research protocols.

Trends

  • Development of high-purity recombinant Alpha 1-3 Fucosyltransferases optimized for specific research applications.
  • Increasing integration of enzyme assays with high-throughput screening platforms.
  • Growth of custom enzyme conjugation and glycoengineering services.
  • Expansion of product portfolios tailored to multi-species research models (human, mouse, monkey, etc.).
  • Adoption of e-commerce and direct-supply channels to accelerate reagent accessibility.

Opportunities

  • Rising investments in precision medicine and personalized therapeutics that rely on glycan profiling.
  • Expansion of glycosylation research in infectious disease, immunotherapy, and cancer metastasis studies.
  • Partnerships between reagent suppliers and academic consortia or contract research organizations (CROs).
  • Introduction of multiplex assay platforms leveraging fucosyltransferase activity.
  • Growth potential in emerging research markets in Asia-Pacific, Latin America, and the Middle East.

SWOT Analysis of the Alpha 1-3 Fucosyltransferases Market

Strengths

  • Enzymes with well-defined biochemical roles in glycan synthesis and cell signaling pathways.
  • Broad applicability across molecular biology, cell biology, and translational research.
  • Increasing availability of recombinant and validated reagents.
  • Supportive supplier networks and global distribution for key research markers.

Weaknesses

  • High cost of premium research-grade enzymes.
  • Technical variability in enzyme activity between lots and suppliers.
  • Requirement for specialized expertise in glycoscience to fully leverage enzyme utility.
  • Market sensitivity to fluctuations in research funding.

Opportunities

  • Increasing adoption in drug discovery, biomarker development, and therapeutic glycoengineering.
  • Growth of integrated reagent kits and assay platforms involving multiple enzymes.
  • Potential demand from diagnostics and clinical assay markets in the future.
  • Expansion in emerging research geographies with growing life science investments.

Threats

  • Competition from substitute reagents and alternative glycoanalysis technologies.
  • Regulatory and compliance challenges regarding biological reagents.
  • Economic uncertainties affecting R&D spending in academia and industry.
  • Supply chain risks for critical biological materials.

Porter’s Five Forces Analysis

1. Threat of New Entrants – Moderate

  • Entry requires technical expertise, quality validation, and compliance proficiency.
  • Established suppliers with product portfolios and validation data pose barriers.
  • Moderate due to the existence of contract manufacturing options and recombinant expression systems.

2. Bargaining Power of Suppliers – Moderate

  • Raw materials (expression systems, purification matrices) and technology platforms confer some supplier influence.
  • Larger market players reduce dependency through vertical integration or diversified sourcing.

3. Bargaining Power of Buyers – High

  • Research institutions and biopharma companies demand high quality, batch consistency, and validated performance.
  • Multiple suppliers in the market give buyers leverage in pricing and service terms.

4. Threat of Substitutes – Moderate

  • Alternative approaches (e.g., synthetic glycan arrays, chemical glycosylation methods) may substitute enzyme use in certain studies.
  • However, native enzyme function remains critical for many biological investigations.

5. Competitive Rivalry – High

  • Large number of regional and global reagent suppliers.
  • Competition driven by product quality, validation support, pricing, and distribution reach.
  • Continuous innovation in reagent design and application support intensifies competition.

Contact us for more details
https://chemreports.com/contact
Explore more report here-
https://chemreports.com/reports

1. Market Overview of Alpha 1-3 Fucosyltransferases
    1.1 Alpha 1-3 Fucosyltransferases Market Overview
        1.1.1 Alpha 1-3 Fucosyltransferases Product Scope
        1.1.2 Market Status and Outlook
    1.2 Alpha 1-3 Fucosyltransferases Market Size by Regions:
    1.3 Alpha 1-3 Fucosyltransferases Historic Market Size by Regions
    1.4 Alpha 1-3 Fucosyltransferases Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth,  Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Alpha 1-3 Fucosyltransferases Sales Market by Type
    2.1 Global Alpha 1-3 Fucosyltransferases Historic Market Size by Type
    2.2 Global Alpha 1-3 Fucosyltransferases Forecasted Market Size by Type
    2.3 FUT3
    2.4 FUT4
    2.5 FUT5
    2.6 FUT6
    2.7 FUT7
    2.8 Others
3. Covid-19 Impact Alpha 1-3 Fucosyltransferases Sales Market by Application
    3.1 Global Alpha 1-3 Fucosyltransferases Historic Market Size by Application
    3.2 Global Alpha 1-3 Fucosyltransferases Forecasted Market Size by Application
    3.3 Human
    3.4 Mouse
    3.5 Monkey
    3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Alpha 1-3 Fucosyltransferases Production Capacity Market Share by Manufacturers
    4.2 Global Alpha 1-3 Fucosyltransferases Revenue Market Share by Manufacturers
    4.3 Global Alpha 1-3 Fucosyltransferases Average Price by Manufacturers
5. Company Profiles and Key Figures in Alpha 1-3 Fucosyltransferases Business
    5.1 R&D Systems
        5.1.1 R&D Systems Company Profile
        5.1.2 R&D Systems Alpha 1-3 Fucosyltransferases Product Specification
        5.1.3 R&D Systems Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.2 Thermo Fisher Scientific
        5.2.1 Thermo Fisher Scientific Company Profile
        5.2.2 Thermo Fisher Scientific Alpha 1-3 Fucosyltransferases Product Specification
        5.2.3 Thermo Fisher Scientific Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.3 Abcam
        5.3.1 Abcam Company Profile
        5.3.2 Abcam Alpha 1-3 Fucosyltransferases Product Specification
        5.3.3 Abcam Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.4 Abbexa
        5.4.1 Abbexa Company Profile
        5.4.2 Abbexa Alpha 1-3 Fucosyltransferases Product Specification
        5.4.3 Abbexa Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.5 Abbiotec
        5.5.1 Abbiotec Company Profile
        5.5.2 Abbiotec Alpha 1-3 Fucosyltransferases Product Specification
        5.5.3 Abbiotec Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.6 Abgent
        5.6.1 Abgent Company Profile
        5.6.2 Abgent Alpha 1-3 Fucosyltransferases Product Specification
        5.6.3 Abgent Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.7 Abnova
        5.7.1 Abnova Company Profile
        5.7.2 Abnova Alpha 1-3 Fucosyltransferases Product Specification
        5.7.3 Abnova Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.8 antibodies-online
        5.8.1 antibodies-online Company Profile
        5.8.2 antibodies-online Alpha 1-3 Fucosyltransferases Product Specification
        5.8.3 antibodies-online Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.9 Assay Biotechnology
        5.9.1 Assay Biotechnology Company Profile
        5.9.2 Assay Biotechnology Alpha 1-3 Fucosyltransferases Product Specification
        5.9.3 Assay Biotechnology Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.10 Aviva Systems Biology
        5.10.1 Aviva Systems Biology Company Profile
        5.10.2 Aviva Systems Biology Alpha 1-3 Fucosyltransferases Product Specification
        5.10.3 Aviva Systems Biology Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.11 Bioss
        5.11.1 Bioss Company Profile
        5.11.2 Bioss Alpha 1-3 Fucosyltransferases Product Specification
        5.11.3 Bioss Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.12 Cloud-Clone
        5.12.1 Cloud-Clone Company Profile
        5.12.2 Cloud-Clone Alpha 1-3 Fucosyltransferases Product Specification
        5.12.3 Cloud-Clone Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.13 Cohesion Biosciences
        5.13.1 Cohesion Biosciences Company Profile
        5.13.2 Cohesion Biosciences Alpha 1-3 Fucosyltransferases Product Specification
        5.13.3 Cohesion Biosciences Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.14 CUSABIO
        5.14.1 CUSABIO Company Profile
        5.14.2 CUSABIO Alpha 1-3 Fucosyltransferases Product Specification
        5.14.3 CUSABIO Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.15 DLDEVELOP
        5.15.1 DLDEVELOP Company Profile
        5.15.2 DLDEVELOP Alpha 1-3 Fucosyltransferases Product Specification
        5.15.3 DLDEVELOP Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.16 EIAab
        5.16.1 EIAab Company Profile
        5.16.2 EIAab Alpha 1-3 Fucosyltransferases Product Specification
        5.16.3 EIAab Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.17 Elabscience
        5.17.1 Elabscience Company Profile
        5.17.2 Elabscience Alpha 1-3 Fucosyltransferases Product Specification
        5.17.3 Elabscience Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.18 Enogene Biotech
        5.18.1 Enogene Biotech Company Profile
        5.18.2 Enogene Biotech Alpha 1-3 Fucosyltransferases Product Specification
        5.18.3 Enogene Biotech Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
    5.19 Novus Biologicals
        5.19.1 Novus Biologicals Company Profile
        5.19.2 Novus Biologicals Alpha 1-3 Fucosyltransferases Product Specification
        5.19.3 Novus Biologicals Alpha 1-3 Fucosyltransferases Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Alpha 1-3 Fucosyltransferases Market Size
    6.2 North America Alpha 1-3 Fucosyltransferases Key Players in North America
    6.3 North America Alpha 1-3 Fucosyltransferases Market Size by Type
    6.4 North America Alpha 1-3 Fucosyltransferases Market Size by Application
7. East Asia
    7.1 East Asia Alpha 1-3 Fucosyltransferases Market Size
    7.2 East Asia Alpha 1-3 Fucosyltransferases Key Players in North America
    7.3 East Asia Alpha 1-3 Fucosyltransferases Market Size by Type
    7.4 East Asia Alpha 1-3 Fucosyltransferases Market Size by Application
8. Europe
    8.1 Europe Alpha 1-3 Fucosyltransferases Market Size
    8.2 Europe Alpha 1-3 Fucosyltransferases Key Players in North America
    8.3 Europe Alpha 1-3 Fucosyltransferases Market Size by Type
    8.4 Europe Alpha 1-3 Fucosyltransferases Market Size by Application
9. South Asia
    9.1 South Asia Alpha 1-3 Fucosyltransferases Market Size
    9.2 South Asia Alpha 1-3 Fucosyltransferases Key Players in North America
    9.3 South Asia Alpha 1-3 Fucosyltransferases Market Size by Type
    9.4 South Asia Alpha 1-3 Fucosyltransferases Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Alpha 1-3 Fucosyltransferases Market Size
    10.2 Southeast Asia Alpha 1-3 Fucosyltransferases Key Players in North America
    10.3 Southeast Asia Alpha 1-3 Fucosyltransferases Market Size by Type
    10.4 Southeast Asia Alpha 1-3 Fucosyltransferases Market Size by Application
11. Middle East
    11.1 Middle East Alpha 1-3 Fucosyltransferases Market Size
    11.2 Middle East Alpha 1-3 Fucosyltransferases Key Players in North America
    11.3 Middle East Alpha 1-3 Fucosyltransferases Market Size by Type
    11.4 Middle East Alpha 1-3 Fucosyltransferases Market Size by Application
12. Africa
    12.1 Africa Alpha 1-3 Fucosyltransferases Market Size
    12.2 Africa Alpha 1-3 Fucosyltransferases Key Players in North America
    12.3 Africa Alpha 1-3 Fucosyltransferases Market Size by Type
    12.4 Africa Alpha 1-3 Fucosyltransferases Market Size by Application
13. Oceania
    13.1 Oceania Alpha 1-3 Fucosyltransferases Market Size
    13.2 Oceania Alpha 1-3 Fucosyltransferases Key Players in North America
    13.3 Oceania Alpha 1-3 Fucosyltransferases Market Size by Type
    13.4 Oceania Alpha 1-3 Fucosyltransferases Market Size by Application
14. South America
    14.1 South America Alpha 1-3 Fucosyltransferases Market Size
    14.2 South America Alpha 1-3 Fucosyltransferases Key Players in North America
    14.3 South America Alpha 1-3 Fucosyltransferases Market Size by Type
    14.4 South America Alpha 1-3 Fucosyltransferases Market Size by Application
15. Rest of the World
    15.1 Rest of the World Alpha 1-3 Fucosyltransferases Market Size
    15.2 Rest of the World Alpha 1-3 Fucosyltransferases Key Players in North America
    15.3 Rest of the World Alpha 1-3 Fucosyltransferases Market Size by Type
    15.4 Rest of the World Alpha 1-3 Fucosyltransferases Market Size by Application
16 Alpha 1-3 Fucosyltransferases Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation Analysis

By Type

FUT3

  • Involved in Lewis antigen biosynthesis
  • Widely used in cancer and immunology research

FUT4

  • Plays a role in leukocyte adhesion and inflammatory responses
  • Strong demand from cell biology and immunological studies

FUT5

  • Applied in glycoprotein synthesis and disease pathway analysis
  • Moderate but steady research demand

FUT6

  • Associated with inflammatory diseases and infection-related pathways
  • Increasing relevance in translational research

FUT7

  • Key enzyme in selectin ligand formation
  • High usage in immune response and hematology research

Others

  • Includes less commonly studied fucosyltransferases
  • Used in exploratory and niche research applications

By Application

Human

  • Largest application segment
  • Extensively used in clinical research, oncology, immunology, and drug discovery
  • Driven by personalized medicine and biomarker development

Mouse

  • Widely used in preclinical studies and genetic research
  • Strong demand from academic and pharmaceutical R&D labs

Monkey

  • Applied in advanced translational and comparative studies
  • Limited but high-value research applications

Others

  • Includes other animal models and in-vitro systems
  • Used in experimental glycoscience research

Competitive Landscape and Key Players Analysis

The Alpha 1-3 Fucosyltransferases market is highly fragmented, with competition centered on product specificity, antibody and enzyme purity, validation data, and global distribution capability. Companies focus on expanding recombinant enzyme portfolios, improving assay compatibility, and supporting translational research.

Key players operating in the global market include:

  • R&D Systems
  • Thermo Fisher Scientific
  • Abcam
  • Abbexa
  • Abbiotec
  • Abgent
  • Abnova
  • antibodies-online
  • Assay Biotechnology
  • Aviva Systems Biology
  • Bioss
  • Cloud-Clone
  • Cohesion Biosciences
  • CUSABIO
  • DLDEVELOP
  • EIAab
  • Elabscience
  • Enogene Biotech
  • Novus Biologicals

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.